Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG)

C. Thallinger, P. Berzinec, E. Bicakcic, A. Dan, G. Fabian, LN. Gales, CG. Kuhar, U. Janzic, Z. Kahan, M. Mencinger, G. Penthedourakis, J. Sgouros, L. Simetic, D. Sirbu, M. Vosmik, A. Wrona, C. Zielinski

. 2022 ; 134 (19-20) : 697-704. [pub] 20220321

Jazyk angličtina Země Rakousko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22033230

PURPOSE: To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). METHODS: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. RESULTS: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). CONCLUSION: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‐2 (severe acute respiratory syndrome coronavirus type 2) pandemic.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22033230
003      
CZ-PrNML
005      
20230131151319.0
007      
ta
008      
230120s2022 au f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00508-022-02016-z $2 doi
035    __
$a (PubMed)35312859
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a au
100    1_
$a Thallinger, Christiane $u Central European Cooperative Oncology Group, Ohmanngasse 26, 1190, Vienna, Austria. christiane.thallinger@cancer-center.cc $u Department of Medicine I, Medical University Vienna-General Hospital, Waehringer Guertel 18-20, 1090, Vienna, Austria. christiane.thallinger@cancer-center.cc $1 https://orcid.org/000000032714535X
245    10
$a Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe : An initiative of the Central European Cooperative Oncology Group (CECOG) / $c C. Thallinger, P. Berzinec, E. Bicakcic, A. Dan, G. Fabian, LN. Gales, CG. Kuhar, U. Janzic, Z. Kahan, M. Mencinger, G. Penthedourakis, J. Sgouros, L. Simetic, D. Sirbu, M. Vosmik, A. Wrona, C. Zielinski
520    9_
$a PURPOSE: To establish a transborder virtual tumor board (VTB) fostering state-of-the-art management of cancer patients by exchanging knowledge and expertise among oncologists in Central and Southeastern Europe (CEE). METHODS: We established and implemented a VTB based on the WebEx platform. This allowed for password-protected and secure upload of patient cases to be presented and discussed among colleagues from various oncology centers scattered throughout CEE in order to arrive at a recommendation for further diagnoses and/or treatment. RESULTS: A total of 73 cases from 16 oncology centers located in 11 CEE countries were uploaded by 22 physicians; 71 were discussed over the course of 17 virtual meetings between June 2018 and May 2019 and 12 different kinds of malignant diseases were discussed with lung cancer (46.6%), melanoma (19.2%) and bladder cancer (13.6%) being the most commonly presented tumor entities. Of the discussed patients, 93.3% had stage IV disease at the time of presentation, 62.6% received chemotherapy or targeted treatment and 67.1% were treated with immune checkpoint inhibitors (ICPIs). The most common causes for presentation and discussion of patient cases were related to the use of ICPIs (80%). CONCLUSION: When the need for expertise exceeds locally available resources, web-based VTBs provide a feasible way to discuss patient cases and arrive at conclusions regarding diagnoses and/or treatment across large geographic distances. Moreover, VTBs provide an innovative way for proper, state-of-the-art management of patients with malignant diseases in times of social distancing and the resulting need for restricted interaction during the current SARS-CoV‐2 (severe acute respiratory syndrome coronavirus type 2) pandemic.
650    _2
$a lidé $7 D006801
650    _2
$a inhibitory kontrolních bodů $7 D000082082
650    _2
$a SARS-CoV-2 $7 D000086402
650    12
$a COVID-19 $x epidemiologie $7 D000086382
650    12
$a nádory plic $7 D008175
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Berzinec, Peter $u Department of Oncology at the Hospital of St Zoerardus Zobor, Nitra, Teaching Base of the Slovak Medical University Bratislava, Bratislava, Slovakia
700    1_
$a Bicakcic, Emina $u Oncology Unit, Clinical Center of Sarajevo University, Sarajevo, Bosnia and Herzegovina
700    1_
$a Dan, Adelina $u Department of Medical Oncology at Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
700    1_
$a Fabian, Gabriella $u Department of Oncotherapy, University of Szeged, Szeged, Hungary
700    1_
$a Gales, Laurentia Nicoletta $u Department of Oncology at UMF "Carol Davila", Bucharest, Romania
700    1_
$a Kuhar, Cvetka Grasic $u Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
700    1_
$a Janzic, Urska $u Department of Medical Oncology, University Clinic Golnik, Golnik, Slovenia
700    1_
$a Kahan, Zsusanna $u Department of Oncotherapy, University of Szeged, Szeged, Hungary
700    1_
$a Mencinger, Marina $u Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
700    1_
$a Penthedourakis, George $u Department of Medical Oncology, University Hospital of Ioannina, Ioannina, Greece
700    1_
$a Sgouros, Joseph $u 3rd Medical Oncology Department, "Agii Anargiri" General Hospital and Cancer Center, Athens, Greece
700    1_
$a Simetic, Luka $u Department of Oncology, University Hospital Centre Zagreb, Zagreb, Croatia
700    1_
$a Sirbu, Daniela $u Oncohelp Oncology Center, Timisoara, Romania
700    1_
$a Vosmik, Milan $u Department of Oncology and Radiotherapy, University Hospital Hradec Králové, Hradec Králové, Czech Republic
700    1_
$a Wrona, Anna $u Department of Oncology and Radiotherapy, Medical University Gdansk, Gdansk, Poland
700    1_
$a Zielinski, Christoph $u Central European Cooperative Oncology Group, Ohmanngasse 26, 1190, Vienna, Austria $u Vienna Cancer Center, Vienna Hospital Association and Medical University Vienna, Vienna, Austria
773    0_
$w MED00010762 $t Wiener klinische Wochenschrift $x 1613-7671 $g Roč. 134, č. 19-20 (2022), s. 697-704
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35312859 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230120 $b ABA008
991    __
$a 20230131151315 $b ABA008
999    __
$a ok $b bmc $g 1891790 $s 1184565
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 134 $c 19-20 $d 697-704 $e 20220321 $i 1613-7671 $m Wiener klinische Wochenschrift $n Wien Klin Wochenschr $x MED00010762
LZP    __
$a Pubmed-20230120

Najít záznam

Citační ukazatele

Možnosti archivace